Oday Elmanaseer, M.D.
Assistant Professor
On This Page
About Oday Elmanaseer
Clinical Profile
Specialties
- General Internal Medicine
Subspecialties
- Hematology
- Medical Oncology
Publications
Academic Articles
-
T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab).
- Journal
- BMJ case reports.
- Volume/Issue
- 15(3)
- [DOI]
- 10.1136/bcr-2021-245603.
- [PMID]
- 35351740.
-
Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia.
- Journal
- BMJ case reports.
- Volume/Issue
- 14(12)
- [DOI]
- 10.1136/bcr-2021-245557.
- [PMID]
- 34937753.
Grants
-
Implementation of Electronic Patient-Reported Outcomes Monitoring During Cancer Treatment: University of Florida Health System
Active
- Role:
- Co-Investigator
- Funding:
- PATIENT-CENTERED OUTCOMES RES INST
Education
-
Hematology and Medical Oncology Fellowship
Georgetown University Hospital
-
Internal Medicine Residency
Albany Medical College, Albany Medical Center Hospital
-
Medical Degree
Jordan University of Science & Technology
Contact Details
- Business:
- (904) 244-1680
- Business:
- oday.elmanseer@jax.ufl.edu
- Business Street:
-
655 W 8TH ST
JACKSONVILLE FL 32209